{"raw_mentions": "the potential epitope is considered as the epitope when IC50 is less than 1000 nM;\nFurther, in step S6, the RFF cells obtained in step S5 are resuspended in OKM-200+5% FBS, and then a monoclonal antibody drug with a final concentration of 50-200 \u03bc g/mL is added to block the immunosuppressive signal molecules of the RFF cells. \nFurther, in the polypeptide impact, polypeptide impact is carried out by using polypeptide solution with the concentration of 10 to 100 mu g/mL."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<1000", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "monoclonal antibody drug", "protein_target_name": null, "binding_metric": null, "value": "50-200", "unit": "\u03bcg/mL", "is_logarithmic": false}, {"molecule_name": "polypeptide solution", "protein_target_name": null, "binding_metric": null, "value": "10 to 100", "unit": "mu g/mL", "is_logarithmic": false}]}
{"raw_mentions": "A potential epitope is considered to be an \"epitope\" if IC50 &lt; 1000 nM."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<1000", "unit": "nM", "is_logarithmic": false}]}
{"raw_mentions": "2) the IC50 of potential epitopes was analyzed using prediction software (recommendation software: NetMHCpan3.0, PickPocket, and Artificial Neural Networks (ANN)), and if IC50 &lt; 1000nM, the potential epitope is considered to be an \"epitope\"."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "IC50", "value": "<1000", "unit": "nM", "is_logarithmic": false}]}
